The 11 countries left in the Trans-Pacific Partnership following the withdrawal of the United States are still looking to finalize the deal. One of the changes they are considering, now that the U.S. has left, is to eliminate rules that would require countries to strengthen patent related protections for prescription drugs. These protections could hugely raise the price of prescription drugs. Patents and related protections can often be equivalent to tariffs of several thousand percent on the...
Published on August 28, 2017 21:41